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Interactions of Eph-related receptors and ligands confer
rostrocaudal pattern to trunk neural crest migration
Catherine E. Krull*, Rusty Lansford*, Nicholas W. Gale†, Andres Collazo*,
Christophe Marcelle*, George D. Yancopoulos†, Scott E. Fraser* 
and Marianne Bronner-Fraser*
Background: In the trunk of avian embryos, neural crest migration through the
somites is segmental, with neural crest cells entering the rostral half of each
somitic sclerotome but avoiding the caudal half. Little is known about the
molecular nature of the cues — intrinsic to the somites — that are responsible for
this segmental migration of neural crest cells.
Results: We demonstrate that Eph-related receptor tyrosine kinases and their
ligands are essential for the segmental migration of avian trunk neural crest cells
through the somites. EphB3 localizes to the rostral half-sclerotome, including
the neural crest, and the ligand ephrin-B1 has a complementary pattern of
expression in the caudal half-sclerotome. To test the functional significance of
this striking asymmetry, soluble ligand ephrin-B1 was added to interfere with
receptor function in either whole trunk explants or neural crest cells cultured on
alternating stripes of ephrin-B1 versus fibronection. Neural crest cells in vitro
avoided migrating on lanes of immobilized ephrin-B1; the addition of soluble
ephrin-B1 blocked this inhibition. Similarly, in whole trunk explants, the
metameric pattern of neural crest migration was disrupted by addition of soluble
ephrin-B1, allowing entry of neural crest cells into caudal portions of the
sclerotome. 
Conclusions: Both in vivo and in vitro, the addition of soluble ephrin-B1 results
in a loss of the metameric migratory pattern and a disorganization of neural
crest cell movement. These results demonstrate that Eph-family receptor
tyrosine kinases and their transmembrane ligands are involved in interactions
between neural crest and sclerotomal cells, mediating an inhibitory activity
necessary to constrain neural precursors to specific territories in the developing
nervous system.
Background
During embryonic development, neural crest cells migrate
along stereotypic pathways to their target destinations,
where they differentiate into much of the peripheral
nervous system, including sensory and sympathetic ganglia
[1,2]. In the trunk of the avian embryo, neural crest migra-
tion through the somite is segmental, with neural crest
cells entering the rostral half of each somitic sclerotome
but avoiding the caudal half [3,4]. Previous studies have
shown that cues intrinsic to the somites are responsible for
this segmental migration and that similar mechanisms may
influence the guidance of motor and sensory axons [5–7].
Inhibitory molecules localized to caudal sclerotomes and/or
attractive molecules present in rostral sclerotomes could
contribute to segmental patterning. A number of candidate
molecules have the expected spatiotemporal localization:
for example, chondroitin sulfate proteoglycans [8–10], T-
cadherin [11] and peanut agglutinin (PNA)-binding
molecules [8] are all expressed in the caudal half-sclero-
tome, whereas butyrylcholinesterase is expressed in the
rostral half-sclerotome [12]. However, functional experi-
ments are required to elucidate the role, if any, of these
molecules in cell migration. We recently developed an
explant preparation that allows direct visualization of
neural crest migration in normal living tissue and offers
accessibility to perturbing reagents [13,14]. Here, we
report functional studies demonstrating a role for Eph
receptor–ligand interactions in neural crest migration.
Several members of the Eph family of receptor tyrosine
kinases and their ligands display intriguing patterns of
expression in the developing nervous system, suggesting
that they may play a role in early neural patterning
[15–20]. On the basis of their binding specificities, the
Eph receptors can be divided into two major subclasses:
EphB-related receptors, which interact primarily with a
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transmembrane subclass of ligands, and EphA-related
receptors, which interact primarily with a glycosylphos-
phatidylinositol-linked subclass of ligands [15,18]. Eph
receptor–ligand interactions have been implicated in
axonal patterning events, such as the topographic organi-
zation of the retinotectal projection and axonal fascicula-
tion [21–25]. Members of this family also are expressed in
the developing forebrain and hindbrain [16,20,26–28] and
appear to play a role in their regional organization [28–30].
The potential role of these molecules in the patterning of
neural precursors in the developing peripheral nervous
system remains largely unexplored. (In this manuscript,
we refer to the Eph family receptors and ligands using a
new nomenclature that has been agreed upon by the Eph
Nomenclature Committee [31].)
Results
The EphB3 receptor is expressed in the neural crest and
rostral sclerotome
To detect receptors of the EphB subclass during trunk
neural crest migration, a fusion protein comprising a repre-
sentative transmembrane ligand, ephrin-B1, and the Fc
portion of human IgG1 (ephrin-B1-Fc) was used to stain
whole chick embryos [18,32]. Ligand–receptor interactions
among members of a subclass are known to be promiscu-
ous, and the ligand ephrin-B1-Fc has the potential to inter-
act with receptors EphB1 (Elk/Cek6), EphB2
(Nuk/Cek5/Qek5) and EphB3 (Hek2/Sek4/Cek10), but
not EphB4 (Htk/MDK2/Myk1) [18,19].
Receptors recognized by ephrin-B1-Fc appeared first in
the rostral portion of mature somites at the 15-somite
stage (stage 12 [33]), coincident with the onset of neural
crest migration (data not shown); this pattern persisted
and became more distinct by the 25-somite stage (stage
15; Figure 1a) through the 35-somite stage (stage 19).
Longitudinal sections revealed that the receptors were
associated with the surface of cells in the rostral half-scle-
rotome (Figure 1b). Identical results were observed in
chick (Figure 1) and quail (data not shown) embryos.
To identify the specific Eph receptors that may account
for the staining associated with neural crest migratory
pathways, we carried out in situ hybridizations with quail-
specific probes for two members of the EphB subclass,
EphB3 [34], and EphB2 [24,35]. At the forelimb level of
the 25-somite embryo, EphB3 transcripts localized within
cells in the rostral half-sclerotome during neural crest
migration (Figure 1c). In contrast, no transcripts were
apparent in the 4–5 most recently formed epithelial
somites, prior to both the time of sclerotome formation and
the entry of neural crest cells. Double-labeling with anti-
HNK-1 antibody, a neural crest marker, showed that all
neural crest cells expressed EphB3 mRNA (Figure 1d–f).
Other EphB3-positive cells in the rostral half-sclerotome
and dermomyotome were HNK-1-negative, and even
extended into the perinotochordal space, which is devoid
of neural crest cells. These labelling patterns indicate that
cells within the rostral half-somite other than neural crest
cells also express EphB3. In contrast to EphB3, EphB2 was
expressed weakly in the rostral sclerotome only at later
stages of neural crest migration (data not shown). These
results suggest that migrating neural crest cells express
EphB3, consistent with their ability to be recognized by
ephrin-B1-Fc.
The ephrin-B1 ligand is distributed in the caudal sclerotome
To investigate the distribution of transmembrane ligands
during the process of trunk neural crest migration, a repre-
sentative receptor-Fc fusion protein (EphB2-Fc) was used
to label whole chick embryos. EphB2-Fc has the potential
to interact with Eph family transmembrane ligands,
including ephrin-B1, ephrin-B2 and ephrin-B3 [18,36]. At
the 10-somite stage, ligands recognized by EphB2-Fc
were expressed highly in the caudal portion of all somites,
including immature epithelial somites (prior to neural
crest migration). During active neural crest migration,
EphB2-Fc staining persisted in the caudal half of each
somite (Figure 2a; 25-somite stage). Longitudinal sections
showed that ligands were associated with the surfaces of
the caudal half-sclerotome and some dermomyotome cells
(Figure 2b). Throughout neurulation, staining was present
within the open neural plate (data not shown) and in the
recently closed neural tube (Figure 2a). 
To identify the ligands bound by EphB2-Fc in the caudal
half-sclerotome, in situ hybridization was carried out in
whole chick embryos with probes for ephrin-B1 and ephrin-
B2 mRNA [37]. In 25-somite embryos, ephrin-B1 mRNA
was observed in a segmental pattern in the caudal halves
of somites along the body axis. Longitudinal sections con-
firmed that ephrin-B1 transcripts were expressed by caudal
half-sclerotome cells (Figure 2c), and were absent from
the rostral half-sclerotome through which neural crest
cells migrate (Figure 2d). Ephrin-B2 was not expressed in
the somite, but was localized to endothelial cells posi-
tioned at the intersomitic boundary (Figure 2e). The
chick homolog of ephrin-B3 has not been isolated and so
its pattern of expression during trunk neural crest migra-
tion was not investigated. 
Soluble ephrin-B1 disrupts the segmental pattern of neural
crest migration in whole trunk explants
The reciprocal distribution of receptors and ligands
suggests that they may play a role in conferring the seg-
mental pattern of neural crest migration. Specifically,
neural crest cells expressing EphB3 may interact with
caudal sclerotome cells expressing ephrin-B1, mediating an
inhibitory event that prohibits entry of neural crest into
this caudal domain. To test this hypothesis, soluble ephrin-
B1-Fc was added to whole trunk explants [13] to disrupt
receptor–ligand interactions. The subsequent distribution
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of migrating neural crest cells was assayed by anti-HNK-1
antibody labeling or by pre-labeling the neural tube with
the lipophilic dye DiI [38]. In the presence of ephrin-B1-
Fc (1 µg/ml or 10 µg/ml), the normally segmental migratory
pattern of neural crest cells was disrupted: labeled cells
were observed in both rostral and caudal portions of the
sclerotome (Figure 3a; Table 1; n = 42), as confirmed by
sectioning the explants (data not shown). In the presence
of 10 µg/ml monomeric ephrin-B1-myc — used to test
whether the disruption resulted from the dimeric nature of
ephrin-B1-Fc — neural crest cells were again observed in
both halves of the somite (Figure 3b; n = 16). In contrast,
treatment with soluble Fc (Figure 3c; 10 µg/ml; n = 20),
COS cell supernatant (concentrated similarly to ephrin-B1-
myc; n = 12), or soluble EphB2-Fc (10–50 µg/ml; n = 25;
data not shown) did not alter the segmental pattern of
neural crest migration. 
To quantitate these effects on neural crest patterning, we
counted the numbers of cells in the rostral and caudal
halves of somites treated with ephrin-B1-Fc, ephrin-B1-
myc or Fc (n = 16 somites in 8 explants per condition;
Table 1). In Fc-treated somites, 2% (8/488) of the neural
crest cells entered the caudal sclerotome. In contrast, 33%
(296/896) of neural crest in ephrin-B1-Fc-treated somites
and 47% (486/1035) of neural crest in ephrin-B1-myc-
treated somites entered the caudal sclerotome (Table 1).
These results indicate that binding the EphB3 receptor
with excess, soluble ephrin-B1 protein allows neural crest
cells to enter the caudal sclerotome domain.
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Figure 1
Staining of 25-somite chick embryos with ephrin-B1-Fc and
hybridization with an EphB3 cDNA probe reveals that Eph receptors are
distributed on cells in the rostral half of the somitic sclerotome, including
neural crest. (a) In a whole-mount preparation, ephrin-B1-Fc staining,
visualized with anti-human Fc antibody coupled to alkaline phosphatase,
is distributed in a segmental fashion in the developing somites. (b) A
longitudinal section shows ephrin-B1-Fc staining localized primarily to
rostral sclerotome; the brackets indicate the rostrocaudal extent of the
somite, with the tick-mark representing the intrasomitic border. (c) A
longitudinal section of another 25-somite embryo after whole-mount in
situ hybridization shows that EphB3 transcripts are present throughout
the rostral sclerotome. (d) The section in (c) was stained with anti-HNK-
1 antibody to mark migrating neural crest cells within the rostral
sclerotome. (e,f) A higher magnification view of the boxed region in (d)
shows that all HNK-1-positive neural crest cells in the rostral sclerotome
express EphB3 mRNA; small arrows mark two examples of double-
labeled cells. Other rostral sclerotomal, dermomyotomal and ectodermal
cells are recognized by ephrin-B1-Fc and EphB3 cDNA, but not HNK-1
antibody. Abbreviations: r, rostral; c, caudal; nt, neural tube; dm,
dermomyotome.
Figure 2
Staining of 25-somite chick embryos with EphB2-Fc and hybridization
with an ephrin-B1 cDNA probe reveals that transmembrane ligands
are distributed on cells in the caudal sclerotome. (a) In a whole-mount
preparation, EphB2-Fc staining, visualized with anti-human Fc antibody
coupled to alkaline phosphatase, is found in the caudal halves of
somites. (b) A longitudinal section through the trunk reveals EphB2-Fc
staining in caudal sclerotome as well as the dermomyotome. (c) A
longitudinal section through an embryo after in situ hybridization with
an ephrin-B1 cDNA probe reveals that ephrin-B1 transcripts are
present in caudal sclerotomal cells. (d) The same section as (c) after
staining with anti-HNK-1 antibody to recognize migrating neural crest
cells reveals that ephrin-B1 is expressed in a pattern complementary
to the distribution of neural crest cells. (e) A longitudinal section of an
embryo after hybridization with an ephrin-B2 probe reveals that these
transcripts localize to endothelial cells at intersomitic borders, but not
sclerotome. Brackets indicate the rostrocaudal extent of a single
somite, with the midline representing the intrasomitic border.
Abbreviations: r, rostral; c, caudal; nt, neural tube; dm, dermomyotome.
Time-lapse analysis of neural crest migration in the
presence of ephrin-B1
To define more clearly the defects in cell migration
caused by the presence of ephrin-B1-Fc, DiI-labeled
neural crest cells were followed in explants using time-
lapse videomicroscopy. In control explants [13], the neural
crest cells entered only the rostral half-sclerotome. Expo-
sure to soluble ephrin-B1-Fc resulted in neural crest cells
emigrating directly from the neural tube into both rostral
and caudal somitic halves (Figure 4).
The trajectories and rates of migration for individual
cells in trunk explants treated with ephrin-B1-Fc,
EphB2-Fc or Fc were acquired from the time-lapse
recordings with an automated cell-tracking program (S.
Speicher and J. Solomon, unpublished). In ephrin-B1-
Fc-treated explants, the trajectories of cells in both the
rostral and caudal somite halves appeared more erratic
and disorganized than those in control cultures
(Figure 4). Surprisingly, the ephrin-B1-Fc-treated cells
often moved backwards from the somite to the neural
tube. Quantitative measurements of cell migration
showed that the mean rates of migration were not
significantly different between ephrin-B1-Fc-treated
cells (10.8 ± 3.1 µm/h; n = 53), untreated cells
(14.9 ± 3.0 µm/h; n = 12), EphB2-Fc-treated cells
(13.7 ± 3.8 µm/h; n = 10) or Fc-treated cells
(17.6 ± 2.8 µm/h; n = 14), and were similar to those
reported previously [13]. However, ephrin-B1-Fc treat-
ment caused significant differences in the directionality
of cell migration — defined as the displacement distance
of a cell divided by its total trajectory length — com-
pared with Fc treatment or EphB2-Fc treatment
(Table 2). This was manifest in the disordered migratory
trajectories of neural crest cells in ephrin-B1-Fc-treated
explants, compared with the linear migratory trajectories
observed in controls (compare Figure 4g,h). Interest-
ingly, differences in directionality were noted even at
concentrations of ephrin-B1-Fc (for example, 250 ng/ml)
too low to disrupt segmental migration of neural crest
cells. Analysis of the cell trajectories of ephrin-B1-Fc-
treated cultures showed some of them crossing the intra-
somitic border (7/40 ephrin-B1-Fc-treated cells). In
contrast, such crossings were observed only rarely under
control conditions (1/14 Fc-treated cells and 0/12
untreated cells). Thus, the bearing and directionality of
neural crest migration, but not its rate, were altered by
exogenous ephrin-B1-Fc. 
The disruptive effect of dimeric ephrin-B1-Fc does not
appear to result from an alteration of the polarity of the
somitic sclerotome. The distribution pattern of molecular
markers characteristic of either the rostral or caudal half-
sclerotome were normal in ephrin-B1-Fc-treated explants:
heparan sulfate proteoglycans were present in their typical
position in the rostral half-sclerotome; and PNA-binding
glycoproteins and chondroitin sulfate proteoglycans were
found in their characteristic location in the caudal half-
sclerotome (data not shown). 
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Table 1
Effects of ephrin-B1 on the mean numbers of neural crest cells
in rostral and caudal halves of the sclerotome.
Treatment Number of Rostral Caudal
somites/explants
Fc (control) 16/8 30.1 cells 0.5 cells
Ephrin-B1-Fc 16/8 35.8 cells 18.5 cells
Ephrin-B1-myc 16/8 34.3 cells 30.4 cells
The numbers of cells in the rostral and caudal halves of the sclerotome
in whole explants treated with Fc alone, ephrin-B1-Fc or ephrin-B1-
myc were counted in static images of whole trunk explants labeled with
anti-HNK-1 antibody.
Figure 3
Soluble ephrin-B1 disrupts the segmental
pattern of neural crest migration. Ephrin-B1-
Fc (a), ephrin-B1-myc (b) or Fc alone (c)
were added to trunk explants and static
patterns of neural crest migration were
visualized by anti-HNK-1 antibody staining.
(a,b) Neural crest cells enter both rostral and
caudal-half somites in the presence of either
dimeric ephrin-B1-Fc (a) or monomeric
ephrin-B1-myc (b). (c) In Fc-treated control
explants, neural crest migrate in their typical
segmental pattern through the rostral half of
the somite. Effects were observed with
ephrin-B1-Fc at 1 µg/ml or 10 µg/ml;
treatment with 250 ng/ml and 500 ng/ml had
little or no effect. Arrowheads indicate cells
over the dorsal aspect of the neural tube.
Small arrows mark a few examples of neural
crest cells migrating within the caudal portion
of the somite. Brackets indicate the
rostrocaudal extent of a single somite, with
the midline representing the intrasomitic
border. Abbreviations: r, rostral; c, caudal; nt,
neural tube.
Ephrin-B1 inhibits neural crest migration in vitro
The trunk explant system cannot distinguish whether
exogenous ephrin-B1 acts directly on neural crest cells or
indirectly by binding to rostral sclerotome. We therefore
examined the direct effects of exogenous ephrin-B1
protein on neural crest migration in vitro. Neural crest
cells were plated on a patterned two-dimensional sub-
strate composed of alternating stripes [39,40] of multi-
meric ephrin-B1-Fc plus fibronectin versus fibronectin
alone. The behavior of these cells was compared with cells
on control substrates composed of: alternating stripes of
Fc plus fibronectin versus fibronectin alone; alternating
stripes of fibronectin alone; or alternating stripes of anti-
Fc antibody plus fibronectin versus fibronectin alone. 
Cultured neural crest cells bound ephrin-B1-Fc,
indicating that they maintained expression of receptors
(Figure 5a,b). The cells migrated uniformly on all control
substrates (Figure 5c), but individual cells avoided
migrating on stripes containing ephrin-B1-Fc (n = 31) and
instead migrated on stripes composed of fibronectin alone
(Figure 5d). Time-lapse videomicroscopy of migrating
neural crest on these striped substrates indicated that the
cells displayed a typical avoidance response consisting of
lamellipodial collapse and process retraction in the
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Figure 4
Time-lapse analysis of individual cell migration
in control and ephrin-B1-Fc-treated explants.
DiI-labeled neural crest cells migrating in trunk
explants were followed using time-lapse
videomicroscopy with images acquired at
2 min intervals. This figure illustrates two
representative frames taken at 0 and 10 h.
The positions of four cells (cells 1–4) in
control Fc-treated explants (a–c) and six cells
(cells 5–10) in ephrin-B1-Fc-treated explants
(d–f) were followed using a cell-tracking
program. The green numbers overlie the initial
(a,d) and later (b,c,e,f) positions of the cells.
The arrows in (c,f) indicate the vectors
between the two frames, with arrowheads
marking the position of the cell after 10 h and
the tail at the position of the cell at its initial
time of observation. The length of the vector
gives the total distance traveled in 10 h. The
dotted red line represents the lateral edge of
the neural tube (nt). The red bracket indicates
the rostrocaudal extent of the somites, with
the intrasomitic border in the midline; r,
rostral; c, caudal. (g,h) Schematic of
trajectories of neural crest cells in control Fc
(g) and ephrin-B1-Fc-treated (h) explants.
Vectors of individual cell movements were
plotted at 30 min time intervals and joined to
record the trajectories of individual neural
crest cells. The cell migration vectors shown
are representative of several time lapse
sequences; cells tracked from different films
are indicated by differing line thicknesses.
Under control conditions, cell moved in an
overall linear manner in the somites and were
constrained to the rostral half of the
sclerotome. In contrast, cell movement in
ephrin-B1-Fc-treated cultures was tortuous,
with cells located in both halves of the
sclerotome moving in a random, disorganized
fashion.
Table 2
The effects of ephrin-B1 and EphB2 on the directionality of
neural crest migration.
Treatment Concentration Number of explants Directionality
Fc (control) 10 µg/ml 14 0.37 ± 0.11
Ephrin-B1-Fc 250 ng/ml 7 0.20 ± 0.14*
Ephrin-B1-Fc 1 µg/ml 41 0.19 ± 0.07*
EphB2-Fc 10 µg/ml 10 0.39 ± 0.13
The directionality of neural crest cell migration, defined as the displace-
ment distance divided by the net distance, was determined for explants
treated with Fc alone, with ephrin-B1-Fc or with EphB2-Fc. Significantly
different levels of directionality were noted between experimental and
control conditions, even in low concentrations of ephrin-B1-Fc which
caused no obvious defects in the pattern of migration; *p < 0.001.
presence of ephrin-B1. The typical broad lamellipod on
the leading process of a migrating neural crest cell under-
went collapse and retraction after crossing into an ephrin-
B1 stripe (Figure 5f). This avoidance behavior did not
occur immediately upon contact with the border of
ephrin-B1, but many minutes after neural crest entry and
process extension on the ephrin-B1 stripe. In contrast,
cells on control substrates did not demonstrate collapse
behavior upon crossing stripes (data not shown). 
To examine further the specificity of these effects, and to
verify that soluble ephrin-B1 interferes with the normal
receptor–ligand interactions, we studied the effects of
adding soluble ephrin-B1 on the behavior of neural crest
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Figure 5
Alternating lanes of ephrin-B1-Fc in vitro
inhibit neural crest migration in a manner that
is mitigated by the addition of soluble ephrin-
B1-Fc. This avoidance by neural crest of
ligand-Fc lanes involves process
collapse/retraction. (a,b) Neural crest cells
grown in vitro were labeled with Fc alone (a)
or ephrin-B1-Fc (b) and visualized with anti-
human Fc antibody coupled to alkaline
phosphatase. (a) Control cultures displayed
no staining. (b) Ephrin-B1-Fc bound
specifically to neural crest cells, indicating
that receptor expression was maintained in
vitro. (c) When migrating neural crest cells
where exposed to a substrate composed of
alternating lanes of fibronectin versus
Fc/fibronectin, they migrated uniformly on
both substrates. (d) When migrating neural
crest cells where exposed to a substrate
composed of alternating lanes of fibronectin
versus antibody-aggregated ephrin-B1-
Fc/fibronectin, they migrated selectively on
the fibronectin lanes, avoiding the lanes
containing multimeric ephrin-B1-Fc. (e) When
soluble ephrin-B1-Fc was added to the
culture medium of neural crest migrating on
alternating lanes of fibronectin versus
antibody-aggregated ephrin-B1-
Fc/fibronectin, they migrated equally well on
all lanes. Analogous results were observed
with monomer ephrin-B1-myc (data not
shown). This demonstrates that soluble
ephrin-B1 functions as a competitive inhibitor
of multimeric ephrin-B1-Fc. (f) Time-lapse
sequences acquired from 5–30 min of a
migrating neural crest cell on striped
substrates to examine ligand avoidance
behavior (at 0 min, cell body was on the
fibronectin (Fn) stripe). Neural crest cell
enters ephrin-B1 lane and extends processes
followed by process collapse and retraction.
(g) Comparison of tyrosine phosphorylation of
the EphB2 receptor in COS7 cells by dimeric
and multimeric ephrin-B1-Fc. Ephrin-B1-Fc
was added at concentrations ranging from
0–10 µg/ml; (–) indicates the addition of the
dimeric form of ephrin-B1-Fc in the absence
of added Fc antibody (Ab), and (+) indicates
the addition of ephrin-B1-Fc in the presence
of anti-Fc antibody. The levels of EphB2
protein are shown below each lane. At 1 and
10 µg/ml, dimeric ephrin-B1-Fc resulted in
substantially lower levels of tyrosine
phosphorylation than did multimeric ephrin-
B1-Fc.
cells on patterned ephrin-B1/fibronectin substrates. After
the addition of soluble dimeric ephrin-B1-Fc (10 µg/ml;
1.7 × 10–7 M; n = 10), neural crest cells migrated equally
well on all lanes (Figure 5e). Analogous results were
obtained with monomeric ephrin-B1-myc (10 µg/ml;
3.3 × 10–7 M; n = 3). The similarity of the two effects
argues that a major mechanism of action of soluble ligand is
via competitive inhibition: ephrin-B1-Fc causes a small but
significant receptor autophosphorylation (Figure 5g),
whereas ephrin-B1-myc causes no signal transduction [32].
In contrast to ligand fusion proteins, soluble EphB2-Fc had
no obvious effect on the patterned migration on ephrin-
B1/fibronectin (data not shown). Our results demonstrate
that lanes of ephrin-B1-Fc can directly inhibit neural crest
migration and verify that soluble ephrin-B1 can function as
a competitive antagonist of this inhibition. 
Treatment with ephrin-B1 induces receptor
phosphorylation 
The phosphorylation status of endogenous EphB2
receptor expressed by COS7 cells was examined after the
addition of 1 or 10 µg/ml of clustered or dimeric ephrin-
B1-Fc.  Even at 1 µg/ml, clustered ephrin-B1-Fc induced
saturating levels of tyrosine phosphorylation of EphB2
(Figure 5g). In contrast, substantially lower levels of tyro-
sine phosphorylation were observed with 1 or 10 µg/ml of
unclustered dimeric ephrin-B1-Fc. EphB2 tyrosine phos-
phorylation was not observed in untreated COS7 cells
(Figure 5g) or in ephrin-B1-myc treated COS7 cells [32]. 
Discussion
In the present study, we have examined whether
members of the Eph family of receptors and ligands par-
ticipate in the segmental patterning of neural crest migra-
tion. Ligand-Fc and receptor-Fc fusion proteins were used
to identify the distribution of their respective subclass of
receptors and ligands [18]. Staining with ephrin-B1-Fc and
in situ hybridization with receptor-specific probes showed
the strong expression of EphB3 (Figure 1) and weak
expression of EphB2 in the rostral half-sclerotome. The
strong binding of ephrin-B1-Fc and expression of EphB3
by neural crest cells as they migrate is consistent with the
previous observation that the ligand ephrin-B1 binds with
high affinity to EphB3 [18,41]. The cognate ligands are
present in the caudal half of each sclerotome, from which
neural crest cells are normally absent, first appearing prior
to neural crest migration (Figure 2). Using in situ
hybridization with ligand-specific probes, we found that
the ligand ephrin-B1, but not ephrin-B2, was expressed in
the caudal half-sclerotome in a pattern consistent with
EphB2-Fc labeling (Figure 2). In studies of axon guidance
and fasciculation [42,43], an emerging theme is that inter-
actions between Eph receptors and their ligands mediate
repulsive signals that constrain growing axons to particular
regions in the developing nervous system. The comple-
mentary expression patterns of the EphB3 receptor and
the ephrin-B1 ligand in avian somites raises the intriguing
possibility that Eph interactions constrain the migration of
neural crest cells to the rostral sclerotome. 
To test the functional significance of this complementary
distribution of receptors and ligands, we examined neural
crest migration both in vivo and in vitro. In a whole trunk
explant system [13], the addition of soluble ephrin-B1 dis-
rupted the patterned migration of neural crest cells in
their native environment (Figure 3). Neural crest cells
were observed within both rostral and caudal halves of
each somitic sclerotome after exposure to ephrin-B1-myc
or ephrin-B1-Fc, suggesting that the normal inhibitory
action of the caudal half-sclerotome on neural crest cells
had been blocked. A significant increase in the numbers
of neural crest cells within the somites in the presence of
ephrin-B1-myc or ephrin-B1-Fc compared with controls
was noted. One possibility to account for this increase in
cell number is that neural crest entered the somite prema-
turely in treated explants. Using an in vitro assay (alternat-
ing lanes of ephrin-B1/fibronectin), we determined that
ephrin-B1 ligand can directly inhibit neural crest cells
(Figure 5), causing collapse and retraction of cell
processes, analogous to growth cone collapse behavior dis-
played by neurons in culture [21]. 
Of note, the repulsive activity of ephrin-B1 on migrating
neural crest in vitro does not appear as an immediate con-
sequence of cell contact with ligand, but instead develops
over many minutes. The addition of soluble ephrin-B1
(either monomeric or dimeric) blocked this inhibition,
such that neural crest cells migrated uniformly on all
lanes. As monomeric ephrin-B1-myc fails to activate signal
transduction [32], it functions solely as an antagonist;
dimeric ephrin-B1-Fc activates low levels of receptor
phosphorylation (Figure 5g) and may function as both an
antagonist and a weak agonist. These results show that
substrate-bound ephrin-B1 directly inhibits neural crest
cell migration, and that soluble ephrin-B1 disrupts this
inhibition. Thus, soluble ephrin-B1 acts as a competitive
inhibitor of ligand binding. The normal rostrocaudal pat-
terning of the somites (as assayed by the metameric
pattern of heparan sulfate proteoglycan in the rostral half-
sclerotome and peanut lectin and chondroitin sulfate pro-
teoglycan in the caudal half-sclerotome), combined with
our in vitro data, suggest that the primary effect of soluble
ephrin-B1 is on the neural crest. 
Time-lapse cinematography revealed major defects and
decreased directionality in the trajectories of the ephrin-
B1-Fc-treated neural crest cells (Figure 4; Table 1).
Although their overall rates of migration were similar to
control and EphB2-Fc-treated explants, neural crest cells
moved in a circular and disoriented fashion in the pres-
ence of ephrin-B1-Fc, sometimes moving across the intra-
somitic border and backwards into the neural tube. This
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disorientation is likely to be due to the activation of signal
transduction pathways in neural crest cells surrounded by
dimeric ephrin-B1-Fc, which may function as a weak
agonist. In support of this possibility, preliminary data (not
shown) suggest that neural crest cells display normal
directionality in the presence of monomeric ephrin-B1-
myc, which does not activate signaling [32]. These data, in
combination, provide interesting mechanistic information
about how Eph receptors might exert their function in
neural crest cells, suggesting a potential link between
receptors and cytoskeletal elements.
Our previous studies demonstrated that treatment of trunk
explants with PNA, which binds to cells in the caudal scle-
rotome [8,44], resulted in neural crest cells migrating
through both rostral and caudal halves of the somite [13].
However, time-lapse recordings reveal different migratory
behaviors in the presence of PNA compared with ephrin-
B1-Fc. In soluble ephrin-B1-Fc-treated explants, both ros-
trally and caudally-located neural crest cells traveled in a
non-linear, disoriented manner (Figure 4). In PNA-treated
explants, by contrast, rostrally located neural crest cells
moved normally, while caudally located neural crest cells
traveled in a highly disorganized manner [13], resembling
neural crest cells in the presence of dimeric ephrin-B1-Fc
(Figure 4). This similarity suggests that neural crest cells
may be receiving repulsive signals in both cases, either
from the exogenous ephrin-B1-Fc or from the ephrin-B1-
expressing caudal sclerotome cells. However, induction of
an abnormal collapse response cannot be the sole explana-
tion for the disruption of the segmental pattern reported
here. Ephrin-B1-myc, which does not stimulate receptor
phosphorylation and signaling [32], alters segmental migra-
tion without eliciting abnormal cell behaviors. The differ-
ential effects observed with PNA and ephrin-B1-Fc
treatment demonstrate that there are likely to be multiple
inhibitory mechanisms in the caudal sclerotome.
The addition of exogenous receptor EphB2-Fc had no
effect on the segmental pattern, rates or continuance of
neural crest migration either in vitro or in vivo. This may
result from the highly adaptive nature of Eph family
receptor–ligand interactions, as observed in previous
studies on the growth of optic axons [25,39]. In stripe
assays, optic axons can adapt to high basal levels of ligand
and grow normally on concentrations dramatically higher
than normally required for growth cone collapse and
repulsion. Similarly, the axons become exquisitely
sensitive to very low levels of ligand in conditions with no
ligand. Thus, if even a fraction of the ligand remained free
to interact in the presence of EphB2-Fc, adaptation would
result in cells that are more sensitive, generating a near-
normal response. Alternatively, the failure of the inhibi-
tion may suggest that EphB2-Fc does not abolish a
higher-order interaction between receptors and ligands, or
an asymmetry in Eph receptor–ligand interactions.
Our functional studies, performed on neural crest cells
migrating in situ, are in agreement with complementary
studies using different assay systems. Both ephrin-A5 and
ephrin-A2 act to inhibit axon outgrowth in the retinotectal
system [21,25,45]; ephrin-A5 has also been implicated in
axon fasciculation by cortical neurons [23]. Ephrin-A5,
expressed by skeletal muscle, inhibits axon outgrowth and
may regulate topographically appropriate neural
connectivity in the peripheral nervous system [46]. Eph
receptors and ligands act in earlier events of neuronal
patterning: expression of a truncated EphA4 receptor dis-
rupts the normal segmental pattern of Krox-20 expression
in the hindbrain of frogs and zebrafish [29], and EphA4,
EphB1 and ligand ephrin-B2 influence the segmental
organization of branchial arch neural crest migration [47]. 
Chick and rat both exhibit metameric expression patterns
of EphB receptors and ephrin-B ligands within the devel-
oping trunk somites, but different members are expressed
in each species. Recently, Wang and Anderson [37]
demonstrated in rat that the ligands ephrin-B2 and ephrin-
B1 have an inhibitory influence on trunk neural crest cells
and motor axons in vitro. Rat neural crest cells primarily
express EphB2, whereas chick neural crest cells predomi-
nantly express EphB3 (Figure 1). In addition, EphB2 and
ephrin-B2 are expressed by rat rostral and caudal sclero-
tome [37], respectively, whereas EphB3 and ephrin-B1 are
present in chick rostral and caudal sclerotome
(Figures 1,2). In rat, ephrin-B1 transcripts are expressed by
cells at the dorsal lip of the dermomyotome [37] and not
by caudal sclerotome cells as observed here in chick and
quail (Figure 2). These findings suggest that there may be
evolutionary conservation within this Eph subclass, but
not necessarily of individual receptors and ligands.
Conclusions
These results demonstrate the presence of Eph family
receptor tyrosine kinases on neural crest and rostral half-
sclerotomal cells, and their cognate ligands in the caudal
half of the sclerotome. Their distribution is consistent
with previous proposals that Eph receptors and their
ligands play roles in establishing boundaries between
regions, probably by mediating repulsive interactions [18].
Furthermore, the presentation of exogenous ephrin-B1 in
a uniform, non-graded fashion disrupts the segmental
patterning of neural crest migration without necessarily
activating signal transduction. By visualizing neural crest
migration in real time in the presence of blocking
reagents, the present experiments offer direct evidence
for Eph ligand–receptor interactions in shaping the migra-
tory routes of neural crest cells.
Materials and methods
Whole embryo staining
EphB2 receptor and ephrin-B1 ligand fusion proteins were constructed
as described [32]. Chick and quail embryos were stained as described
[18]. Whole-mount embryos were photographed and then prepared for
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standard cryostat sectioning. Images were captured using a Roche
ProgRes camera on Zeiss Axiophot or Stemi SV11 microscopes and
processed with Adobe Photoshop 3.0 software.
cDNA probes and in situ hybridization
EphB2 and EphB3 cDNAs were isolated by screening at high stringency
a 4 day quail cDNA library with a PCR fragment of the tyrosine kinase
domain of the QEK5 gene [48]. Two cDNAs were isolated: EphB2 [24]
and EphB3 (encoding proteins with 98% and 91% amino acid similarity,
respectively, to chick EphB3 [33] and human EphB3 [49,50]). In situ
hybridizations were carried out as described [51], except that post-anti-
body washes were done overnight at 4°C in MABT (maleic acid
buffer–tween). The two probes used for EphB3 were: a 1 kb PvuII frag-
ment spanning approximately 500 bp of the extracellular domain and
500 bp of the intracellular domain; and a 1.8 kb fragment encompassing
most of the intracellular domain and about 700 bp of the 3′ untranslated
region. The probes used for EphB2 were: a 1150 bp fragment encom-
passing 1 kb of the intracellular domain and 150 bp of the 3′ untranslated
region; and the entire 3.1 kb EphB2 cDNA. cDNA probes for ephrin-B1
and ephrin-B2 were provided by H. Wang and D. Anderson. Anti-HNK-1
antibody [52] was used to identify neural crest cells in cryosections of
embryos that had been processed for in situ hybridization.
Neural crest cultures
Stripes of alternating substrates were prepared as described [40,53]
with a few modifications. 35 mm UV-sterilized culture dishes were first
coated with a nitrocellulose/methanol solution and allowed to dry under a
sterile hood, followed by application of a sterile stripe matrix. Stripes
were filled three times for 20 min with a solution containing 100µg/ml
fibronectin, polyclonal goat anti-IgG-Fc antibody (250µg/ml; Jackson
Immunoresearch), and Texas Red-BSA (10µg/ml; Sigma), washed and
incubated with 200 µg/ml fibronectin in phosphate-buffered saline (PBS)
for 1 h, followed by a solution of ephrin-B1-Fc (10µg/ml) in PBS for 2 h,
followed by two rinses in PBS and addition of neural crest culture
medium. For some experiments, instead of adding antibody and ligand-Fc
sequentially, a solution of ephrin-B1-Fc (10µg/ml) and the goat anti-IgG-
Fc antibody was preincubated for 1 h at room temperature before this
solution was applied as alternating stripes, as described above. A
fibronectin solution was then applied over the entire dish. To some
dishes, monomeric ephrin-B1-myc (1 or 10µg/ml) or dimeric ephrin-B1-
Fc (1 or 10 µg/ml) was added to the culture medium. 
Primary neural crest cell cultures were prepared from quail embryos, at
stages 12–14 [33], according to standard procedures [53]. Neural
tubes were arranged perpendicular to the striped substrata and placed
in a 5% CO2 culture incubator. Cultures were photographed at 12 and
24 h using fluorescence and phase optics. For time-lapse analysis
using a BioRad MRC 600 confocal microscope (LD Acroplan 40× long
working distance objective), Hepes (pH7.7; 20 mM final) was added to
the medium and cultures were maintained at 37°C in a warming incu-
bator. Images were collected every minute for 40 min to 3 h and were
analyzed using NIH Image 1.61 software. 
Whole trunk explants
Trunk explants were prepared as described [13,14] after prelabeling the
neural tubes with DiI [38]. Trunk regions were pre-incubated in a solution
(0.25–10 µg/ml) of sterile-filtered ligand (ephrin-B1-Fc or ephrin-B1-
myc), EphB2-Fc or Fc alone in culture medium for 4 h at 37°C. They
were placed on Millicell inserts (Millipore) and grown at 37°C in a 5%
CO2 tissue culture incubator for 24–36 h. Some explants were fixed
overnight in 4% paraformaldehyde after 24–36 h in culture and stained
with anti-HNK-1 antibody to mark neural crest. HNK-1-labelled neural
crest cells were counted in the rostral and caudal portions of somites in
ephrin-B1-Fc-treated explants, ephrin-B1-myc-treated explants and
control Fc-treated explants using a Zeiss Axiovert equipped with fluores-
cence and phase optics. Statview software was used to determine the
mean ± standard deviation, and to perform a Student’s two-tailed t-test.
Time-lapse videomicroscopy of whole trunk explants
DiI-labeled neural crest cells were followed by low-light-level videomi-
croscopy as previously described [13]. Time-lapse frames were
converted to digital images using the MetaMorph software (Universal
Imaging Corporation, West Chester, PA). The digital images were
transferred to a Silicon Graphics workstation. Individual cells were fol-
lowed at 30 min intervals and their rates of migration were analyzed
using a cell tracking program (J. Solomon and S. Speicher, Computa-
tional Biology Center, Beckman Institute, California Institute of Technol-
ogy; unpublished data). 
Receptor phosphorylation assays
Receptor phosphorylation was determined as described [18,32].
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